Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

18.80CAD
17 Nov 2017
Change (% chg)

$0.52 (+2.84%)
Prev Close
$18.28
Open
$18.30
Day's High
$18.87
Day's Low
$18.28
Volume
1,068,222
Avg. Vol
1,399,100
52-wk High
$25.22
52-wk Low
$11.20

Select another date:

Tue, Nov 14 2017

BRIEF-Valeant announces pricing of private offering of add-on secured notes

* Valeant announces pricing of private offering of add-on secured notes

BRIEF-Valeant announces launch of private offering of add-on secured notes

* Valeant announces launch of private offering of add-on secured notes

BRIEF-Valeant Pharmaceuticals amends existing credit agreement

Nov 9 Valeant Pharmaceuticals International Inc :

CANADA STOCKS-TSX adds to record highs as Valeant, energy climb

TORONTO, Nov 7 Canada's main stock index added to its record highs on Tuesday, boosted by a jump in the shares of Valeant Pharmaceuticals International Inc after the company's quarterly profit beat estimates, while energy shares also climbed.

Valeant profit beats forecasts on Bausch & Lomb strength

Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit on strength in its Bausch and Lomb eye care business, sending its shares up more than 15 percent.

UPDATE 3-Valeant profit beats forecasts on Bausch & Lomb strength

Nov 7 Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit on strength in its Bausch and Lomb eye care business, sending its shares up more than 15 percent.

BRIEF-Valeant announces Q3 revenue of $2.22 billion

* Q3 revenue $2.219 billion versus I/B/E/S view $2.15 billion

Drugmaker Valeant's revenue falls 10.5 pct

Nov 7 Canada's Valeant Pharmaceuticals International Inc reported a 10.5 percent fall in quarterly revenue on Tuesday, hurt by declining sales in its branded drugs division.

Valeant to sell female libido pill business back to former owners

Valeant Pharmaceuticals International Inc said on Monday it will sell its female libido-pill business Sprout Pharmaceuticals back to its former owners, two years after buying the company for about $1 billion.

Select another date: